Literature DB >> 25034606

TSG-6 protects corneal endothelium from transcorneal cryoinjury in rabbits.

Jeong-Ah Kim1, Jung Hwa Ko2, Ah Young Ko2, Hyun Ju Lee2, Mee Kum Kim3, Won Ryang Wee3, Ryang Hwa Lee4, Samuel F Fulcher5, Joo Youn Oh3.   

Abstract

PURPOSE: To investigate the effect of an anti-inflammatory protein, TNF-α stimulated gene/protein (TSG)-6 and an antiapoptotic protein, stanniocalcin (STC)-1 on corneal endothelium in rabbits with transcorneal cryoinjury.
METHODS: Transcorneal freezing (-80°C) was applied to rabbit corneas for 30 seconds. Immediately post injury, either TSG-6 (10 μg/100 μL), STC-1 (10 μg/100 μL), or the same volume of balanced salt solution (BSS) was injected into the anterior chamber. Each eye was examined for corneal opacity, corneal thickness, endothelial cell density, and endothelial hexagonality every 2 to 6 hours for 48 hours post injury. The concentrations of myeloperoxidase (MPO) and IL-1β were measured in the aqueous humor every 6 hours. At 48 hours post injury, each cornea was assayed for TNF-α, IL-1β, IL-6, and MPO, and histologically evaluated with alizarin red-trypan blue staining, hematoxylin-eosin staining, and immunostaining for neutrophils.
RESULTS: Tumor necrosis factor-α stimulated gene/protein-6 significantly decreased the development of corneal opacity and edema after cryoinjury compared with STC-1 or BSS. The corneal endothelial cell density and hexagonality were markedly preserved by TSG-6. The mRNA levels of TNF-α, IL-1β, and IL-6 in the cornea and the protein levels of MPO and IL-1β in the aqueous humor and cornea were significantly lower in TSG-6-treated eyes than BSS-treated controls. Similarly, the expression of fibroblast growth factor-2 was reduced by TSG-6 treatment. Histologic evaluation demonstrated that neutrophil infiltration of the cornea was decreased in TSG-6-treated eyes.
CONCLUSIONS: Tumor necrosis factor-α stimulated gene/protein-6 protected corneal endothelial cells from transcorneal cryoinjury through suppression of inflammation. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  TSG-6; corneal endothelial cell; inflammation

Mesh:

Substances:

Year:  2014        PMID: 25034606     DOI: 10.1167/iovs.14-14538

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Cutaneous Wounds in Mice Lacking TSG-6 Exhibit Delayed Closure and an Abnormal Inflammatory Response.

Authors:  Sajina Shakya; Judith A Mack; Minou Alipour; Edward V Maytin
Journal:  J Invest Dermatol       Date:  2020-05-15       Impact factor: 8.551

2.  New ex vivo model of corneal endothelial phacoemulsification injury and rescue therapy with mesenchymal stromal cell secretome.

Authors:  Majid Rouhbakhshzaeri; Behnam Rabiee; Nathalie Azar; Elham Ghahari; Ilham Putra; Medi Eslani; Ali R Djalilian
Journal:  J Cataract Refract Surg       Date:  2018-12-07       Impact factor: 3.351

Review 3.  Animal models of corneal endothelial dysfunction to facilitate development of novel therapies.

Authors:  Sangwan Park; Brian C Leonard; Vijay Krishna Raghunathan; Soohyun Kim; Jennifer Y Li; Mark J Mannis; Christopher J Murphy; Sara M Thomasy
Journal:  Ann Transl Med       Date:  2021-08

4.  Hyaluronidase and Hyaluronan Oligosaccharides Promote Neurological Recovery after Intraventricular Hemorrhage.

Authors:  Govindaiah Vinukonda; Preeti Dohare; Arslan Arshad; Muhammad T Zia; Sanjeet Panda; Ritesh Korumilli; Robert Kayton; Vincent C Hascall; Mark E Lauer; Praveen Ballabh
Journal:  J Neurosci       Date:  2016-01-20       Impact factor: 6.167

5.  Intravitreal TSG-6 suppresses laser-induced choroidal neovascularization by inhibiting CCR2+ monocyte recruitment.

Authors:  Sang Jin Kim; Hyun Ju Lee; Ji-Hyun Yun; Jung Hwa Ko; Da Ye Choi; Joo Youn Oh
Journal:  Sci Rep       Date:  2015-07-07       Impact factor: 4.379

6.  Anti-Inflammatory and Anti-Fibrotic Effects of Human Amniotic Membrane Mesenchymal Stem Cells and Their Potential in Corneal Repair.

Authors:  Alejandro Navas; Fátima Sofía Magaña-Guerrero; Alfredo Domínguez-López; César Chávez-García; Graciela Partido; Enrique O Graue-Hernández; Francisco Javier Sánchez-García; Yonathan Garfias
Journal:  Stem Cells Transl Med       Date:  2018-09-10       Impact factor: 6.940

7.  In vitro analysis of the role of tumor necrosis factor‑stimulated gene‑6 in keloid.

Authors:  Xinyi Li; Zhao Chen; Xiaojing Li; Hui Wang
Journal:  Mol Med Rep       Date:  2018-12-14       Impact factor: 2.952

8.  VIP Induces Changes in the F-/G-Actin Ratio of Schlemm's Canal Endothelium via LRRK2 Transcriptional Regulation.

Authors:  Xiaoqin Yan; Mu Li; Zhaoxia Luo; Yin Zhao; Hong Zhang; Liwen Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.